http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-69631141-T2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a135a933620c99beab01d4ac785d25
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0827
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
filingDate 1996-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32d8caa2e9853e8703309bf75f318f0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81714e29383403f4fab35661d2551bfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d79add3f14bc24bb61b589322343bbcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bbbbfde50aed3e228a2563034e36c40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dda62ffe83d1babf650014755b653ba3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_932e18b5e7dbd495f2428f813f1f553d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45a59530d9047317f547f8f9509c48c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c69cc069fae9b7aa39b022cc7b2d88b
publicationDate 2004-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-69631141-T2
titleOfInvention BIOLOGICALLY ACTIVE PEPTIDES AND THEIR PREPARATIONS AND USES
abstract This invention relates to derivatives of hemiasterlin or Geodiamolide G having anti-mitotic activities and useful in treating cancer. These derivatives are represented by general formula I, wherein Y, n, R1, R2, R3, R6, R7, R70, R71, R72, R74, and R75 are as defined in the specification.
priorityDate 1995-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8617114
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41124
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4326917
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37888
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467217279
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43359
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9619310
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9616181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468154535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467226220

Total number of triples: 40.